Bellevue Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.1M Sell
148,203
-26,966
-15% -$8.03M 0.95% 32
2025
Q4
$57.8M Buy
175,169
+5,112
+3% +$1.73M 1.1% 24
2025
Q3
$58.7M Buy
170,057
+27,761
+20% +$8.4M 1.22% 22
2025
Q2
$44.4M Sell
142,296
-22,446
-14% -$8.58M 0.98% 25
2025
Q1
$86.3M Buy
164,742
+5,029
+3% +$2.57M 1.93% 13
2024
Q4
$80.8M Sell
159,713
-65,837
-29% -$37.4M 1.56% 19
2024
Q3
$132M Buy
225,550
+19,875
+10% +$11.2M 2.14% 14
2024
Q2
$105M Buy
205,675
+56,956
+38% +$27.9M 1.7% 18
2024
Q1
$73.6M Buy
148,719
+10,567
+8% +$5.37M 1.12% 24
2023
Q4
$72.7M Sell
138,152
-120,053
-46% -$64M 1.11% 26
2023
Q3
$130M Buy
258,205
+48,078
+23% +$23.7M 2.1% 13
2023
Q2
$101M Buy
210,127
+15,316
+8% +$7.49M 1.44% 20
2023
Q1
$92.1M Sell
194,811
-29,483
-13% -$14.2M 1.34% 19
2022
Q4
$119M Sell
224,294
-72,460
-24% -$38.4M 1.58% 16
2022
Q3
$150M Sell
296,754
-5,290
-2% -$2.78M 2.15% 12
2022
Q2
$155M Sell
302,044
-3,657
-1% -$1.84M 2.19% 10
2022
Q1
$156M Sell
305,701
-6,580
-2% -$3.17M 1.81% 13
2021
Q4
$157M Sell
312,281
-25,701
-8% -$11.6M 1.62% 15
2021
Q3
$132M Sell
337,982
-5,069
-1% -$2.1M 1.34% 20
2021
Q2
$137M Sell
343,051
-14,330
-4% -$5.71M 1.34% 19
2021
Q1
$133M Buy
357,381
+51,336
+17% +$17.8M 1.41% 19
2020
Q4
$107M Sell
306,045
-18,008
-6% -$6.04M 1.23% 27
2020
Q3
$101M Buy
324,053
+17,417
+6% +$5.35M 1.4% 16
2020
Q2
$90.4M Sell
306,636
-9,572
-3% -$2.74M 1.28% 20
2020
Q1
$78.9M Buy
316,208
+40,998
+15% +$11.3M 1.53% 17
2019
Q4
$80.9M Buy
275,210
+36,498
+15% +$9.55M 1.28% 23
2019
Q3
$51.9M Buy
238,712
+44,318
+23% +$10.7M 0.96% 30
2019
Q2
$47.4M Buy
194,394
+61,557
+46% +$14.8M 0.81% 35
2019
Q1
$32.8M Buy
132,837
+1
+0% +$255 1.81% 13
2018
Q4
$33.1M Buy
132,836
+8,988
+7% +$2.37M 2.18% 12
2018
Q3
$32.9M Buy
123,848
+27,119
+28% +$7.05M 2.09% 14
2018
Q2
$23.7M Sell
96,729
-45,861
-32% -$11M 2.02% 14
2018
Q1
$30.5M Sell
142,590
-320
-0.2% -$73.1K 3.02% 6
2017
Q4
$31.5M Buy
142,910
+6,640
+5% +$1.41M 3.29% 6
2017
Q3
$26.7M Buy
136,270
+7,230
+6% +$1.4M 2.79% 9
2017
Q2
$23.9M Buy
129,040
+5,100
+4% +$894K 2.83% 4
2017
Q1
$20.3M Buy
123,940
+13,940
+13% +$2.28M 2.71% 5
2016
Q4
$17.6M Buy
110,000
+10,800
+11% +$1.61M 3.61% 4
2016
Q3
$13.9M Hold
99,200
2.51% 9
2016
Q2
$14M Buy
99,200
+6,200
+7% +$827K 2.64% 6
2016
Q1
$12M Buy
+93,000
New +$11M 2.18% 11

Other funds holding UNH

Bellevue Group's UNH Position: Q1 2026 in Review

Bellevue Group reduced its UnitedHealth (UNH) stake by 15% in Q1 2026, selling an estimated $8.03M and leaving 148,203 shares worth $40.1M. The position accounts for 0.95% of the portfolio, ranked #32.

Bellevue Group first reported a position in UNH in Q1 2016 and has held it in 41 quarters since. The position peaked at $157M in Q4 2021. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Bellevue Group held 148,203 shares of UnitedHealth worth $40.1M as of Q1 2026.
  • Bellevue Group sold 26,966 UnitedHealth shares in Q1 2026, an estimated $8.03M.
  • UnitedHealth made up 0.95% of Bellevue Group's portfolio in Q1 2026, its #32 holding.
  • Bellevue Group first reported a position in UnitedHealth in Q1 2016 and has held it in 41 quarters since.
  • Bellevue Group's UnitedHealth position peaked at $157M in Q4 2021.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.